Safety of Intravenous Olanzapine in a General Hospital Population

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Retrospective review of intravenous olanzapine's safety shows adverse drug effects in inpatients, indicating careful dose management.

IV olanzapine has a safety profile suggesting reasonable use among general hospital inpatients, and monitoring is essential.
Of the 1214 administrations, 7.41% had an adverse drug effect related to vital signs, indicating some risk associated with this therapy.
Higher doses of IV olanzapine (over 5 mg) were linked with a significantly greater incidence of adverse drug effects, necessitating caution.
Data were obtained from a retrospective analysis of 304 inpatients, highlighting the importance of ongoing safety evaluations in IV olanzapine usage.

Dragonetti et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

Retrospective review of intravenous olanzapine's safety shows adverse drug effects in inpatients, indicating careful dose management.

IV olanzapine has a safety profile suggesting reasonable use among general hospital inpatients, and monitoring is essential.
Of the 1214 administrations, 7.41% had an adverse drug effect related to vital signs, indicating some risk associated with this therapy.
Higher doses of IV olanzapine (over 5 mg) were linked with a significantly greater incidence of adverse drug effects, necessitating caution.
Data were obtained from a retrospective analysis of 304 inpatients, highlighting the importance of ongoing safety evaluations in IV olanzapine usage.

Dragonetti et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark